Allied Healthcare Products, Inc. (AHPI) Income Statement Analysis

See more : Medaro Mining Corp. (MEDAF) Income Statement Analysis – Financial Results

Complete financial analysis of Allied Healthcare Products, Inc. (AHPI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allied Healthcare Products, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.

You may be interested

Shree Cement Limited (SHREECEM.BO) Income Statement Analysis – Financial Results
Currency Exchange International, Corp. (CXI.TO) Income Statement Analysis – Financial Results
Skychain Technologies Inc. (SKTCF) Income Statement Analysis – Financial Results
Shandong Zhangqiu Blower Co., Ltd (002598.SZ) Income Statement Analysis – Financial Results
Fiore Cannabis Ltd. (FIORF) Income Statement Analysis – Financial Results

Allied Healthcare Products, Inc. (AHPI)

Industry: Medical - Devices

Sector: Healthcare

Website: https://www.alliedhpi.com

About Allied Healthcare Products, Inc.

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which include construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. The company was incorporated in 1979 and is headquartered in St. Louis, Missouri.

Metric	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991
Revenue	27.05M	36.28M	31.89M	31.38M	33.76M	33.51M	35.95M	35.46M	36.37M	38.55M	43.45M	46.78M	46.03M	52.07M	56.36M	56.50M	57.55M	56.12M	59.10M	60.86M	60.41M	64.93M	64.28M	72.80M	96.50M	118.10M	120.10M	111.60M	74.10M	61.20M	58.60M	54.60M
Cost of Revenue	24.52M	29.17M	26.32M	26.34M	27.31M	26.96M	28.59M	28.39M	29.06M	30.31M	33.48M	35.78M	34.94M	40.27M	43.01M	42.03M	43.29M	41.67M	42.75M	46.81M	50.00M	48.27M	48.05M	55.90M	69.10M	82.40M	80.50M	65.50M	42.60M	35.10M	34.40M	32.30M
Gross Profit	2.53M	7.11M	5.57M	5.04M	6.45M	6.56M	7.36M	7.07M	7.31M	8.24M	9.96M	11.00M	11.09M	11.80M	13.36M	14.47M	14.25M	14.45M	16.35M	14.05M	10.42M	16.66M	16.22M	16.90M	27.40M	35.70M	39.60M	46.10M	31.50M	26.10M	24.20M	22.30M
Gross Profit Ratio	9.34%	19.60%	17.47%	16.06%	19.11%	19.56%	20.47%	19.94%	20.11%	21.38%	22.93%	23.52%	24.09%	22.66%	23.70%	25.62%	24.77%	25.75%	27.67%	23.09%	17.24%	25.66%	25.24%	23.21%	28.39%	30.23%	32.97%	41.31%	42.51%	42.65%	41.30%	40.84%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	0.00	0.00	0.00	8.45M	8.61M	9.28M	8.76M	10.42M	10.74M	10.61M	10.59M	11.87M	13.04M	12.08M	12.05M	12.11M	11.84M	12.66M	13.55M	22.35M	14.57M	16.83M	18.70M	23.90M	33.90M	31.40M	24.80M	16.80M	13.90M	13.40M	12.40M
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	7.11M	7.64M	8.63M	7.81M	8.45M	8.61M	9.28M	8.76M	10.42M	10.74M	10.61M	10.59M	11.87M	13.04M	12.08M	12.05M	12.11M	11.84M	12.66M	13.55M	22.35M	14.57M	16.83M	18.70M	23.90M	33.90M	31.40M	24.80M	16.80M	13.90M	13.40M	12.40M
Other Expenses	0.00	0.00	-18.25K	-130.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-17.60K	2.20M	-3.00M	100.00K	100.00K	2.90M	1.60M	1.10M	1.10M	1.20M
Operating Expenses	7.11M	7.64M	8.63M	7.81M	8.45M	8.61M	9.28M	8.76M	10.42M	10.74M	10.61M	10.59M	11.87M	13.04M	12.08M	12.05M	12.11M	11.84M	12.66M	13.55M	22.35M	14.57M	16.82M	20.90M	20.90M	34.00M	31.50M	27.70M	18.40M	15.00M	14.50M	13.60M
Cost & Expenses	31.63M	36.81M	34.96M	34.16M	35.76M	35.56M	37.87M	37.16M	39.48M	41.05M	44.10M	46.37M	46.82M	53.31M	55.09M	54.08M	55.41M	53.51M	55.41M	60.36M	72.35M	62.84M	64.87M	76.80M	90.00M	116.40M	112.00M	93.20M	61.00M	50.10M	48.90M	45.90M
Interest Income	176.00	233.00	654.00	138.00	288.00	1.45K	2.78K	3.04K	4.82K	12.01K	27.37K	32.73K	10.17K	60.28K	-138.27M	-110.79M	-52.99M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	191.45K	115.98K	64.68K	56.22K	23.57K	0.00	0.00	0.00	0.00	0.00	336.00	66.00	4.27K	0.00	20.15M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	460.93K	579.47K	602.20K	822.08K	931.41K	1.09M	1.23M	1.31M	1.28M	1.31M	1.28M	1.36M	1.36M	1.29M	1.23M	1.23M	1.06M	1.15M	1.31M	1.17M	1.39M	2.95M	3.33M	3.80M	4.90M	5.50M	4.00M	2.90M	1.60M	1.10M	1.10M	1.20M
EBITDA	-4.12M	52.88K	-2.46M	-1.95M	-1.06M	-962.04K	-774.92K	-449.60K	-1.86M	-690.77K	613.34K	1.73M	475.68K	-15.92M	2.56M	3.79M	3.22M	3.60M	4.44M	799.39K	-11.64M	3.36M	923.91K	-2.20M	6.50M	-400.00K	7.30M	17.60M	13.40M	11.80M	9.80M	8.00M
EBITDA Ratio	-15.23%	0.15%	-7.71%	-6.22%	-3.15%	-2.87%	-2.16%	-1.27%	-5.13%	-1.79%	1.41%	3.69%	1.03%	-30.57%	4.54%	6.70%	5.59%	6.41%	7.52%	1.31%	-19.26%	5.18%	1.44%	-3.02%	6.74%	-0.34%	6.08%	15.77%	18.08%	19.28%	16.72%	14.65%
Operating Income	-4.58M	-526.59K	-3.06M	-2.77M	-2.00M	-2.05M	-1.92M	-1.69M	-3.11M	-2.49M	-649.75K	408.91K	-782.22K	-17.22M	1.27M	2.42M	2.14M	2.61M	3.69M	503.04K	-11.93M	2.09M	-594.53K	-4.00M	6.50M	1.80M	8.10M	18.40M	13.10M	11.10M	9.70M	8.70M
Operating Income Ratio	-16.93%	-1.45%	-9.60%	-8.84%	-5.91%	-6.12%	-5.34%	-4.78%	-8.55%	-6.47%	-1.50%	0.87%	-1.70%	-33.07%	2.26%	4.29%	3.72%	4.65%	6.25%	0.83%	-19.75%	3.22%	-0.92%	-5.49%	6.74%	1.52%	6.74%	16.49%	17.68%	18.14%	16.55%	15.93%
Total Other Income/Expenses	-181.78K	2.29M	-82.28K	693.79K	-23.52K	-272.00	-84.07K	-66.98K	-36.84K	496.71K	-20.60K	-45.48K	-111.29K	10.22K	58.11K	134.63K	15.23K	-165.68K	-558.54K	-871.97K	-1.10M	-1.68M	-1.81M	-2.00M	-4.30M	-7.70M	-4.80M	-3.70M	-1.30M	-400.00K	-1.00M	-1.90M
Income Before Tax	-4.76M	1.76M	-3.14M	-2.08M	-2.02M	-2.05M	-2.00M	-1.76M	-3.15M	-2.00M	-670.35K	363.43K	-893.51K	-17.21M	1.33M	2.56M	2.16M	2.44M	3.14M	-368.93K	-13.03M	406.03K	-2.41M	-6.00M	2.20M	-5.90M	3.30M	14.70M	11.80M	10.70M	8.70M	6.80M
Income Before Tax Ratio	-17.61%	4.85%	-9.86%	-6.63%	-5.98%	-6.12%	-5.57%	-4.97%	-8.65%	-5.18%	-1.54%	0.78%	-1.94%	-33.05%	2.36%	4.52%	3.75%	4.35%	5.31%	-0.61%	-21.56%	0.63%	-3.75%	-8.24%	2.28%	-5.00%	2.75%	13.17%	15.92%	17.48%	14.85%	12.45%
Income Tax Expense	599.67K	72.48K	-130.36K	29.45K	173.04K	36.50K	301.43K	16.60K	-339.81K	-740.04K	-245.92K	159.02K	-293.94K	-449.78K	448.75K	914.40K	506.85K	100.78K	1.26M	-211.37K	-1.29M	171.89K	-694.96K	-1.90M	9.00M	-1.40M	1.50M	5.90M	4.50M	4.00M	3.10M	2.50M
Net Income	-5.36M	1.69M	-3.01M	-2.11M	-2.19M	-2.09M	-2.30M	-1.78M	-2.81M	-1.26M	-424.43K	204.41K	-599.57K	-16.76M	882.50K	1.64M	1.65M	2.34M	1.87M	-157.56K	-11.73M	234.14K	-1.71M	-4.10M	-7.40M	-4.50M	1.80M	8.80M	7.30M	6.70M	5.60M	4.30M
Net Income Ratio	-19.82%	4.65%	-9.45%	-6.72%	-6.49%	-6.23%	-6.41%	-5.01%	-7.71%	-3.26%	-0.98%	0.44%	-1.30%	-32.19%	1.57%	2.91%	2.86%	4.17%	3.17%	-0.26%	-19.42%	0.36%	-2.67%	-5.63%	-7.67%	-3.81%	1.50%	7.89%	9.85%	10.95%	9.56%	7.88%
EPS	-1.34	0.42	-0.75	-0.53	-0.55	-0.52	-0.57	-0.44	-0.70	-0.31	-0.10	0.05	-0.15	-4.24	0.22	0.42	0.42	0.60	0.48	-0.04	-3.00	0.06	-0.44	-1.05	-1.90	-1.15	0.50	2.90	2.62	1.88	1.56	1.32
EPS Diluted	-1.34	0.42	-0.75	-0.53	-0.55	-0.52	-0.57	-0.44	-0.70	-0.31	-0.10	0.05	-0.15	-4.24	0.22	0.41	0.41	0.58	0.47	-0.04	-3.00	0.06	-0.44	-1.05	-1.90	-1.15	0.49	2.90	2.62	1.88	1.56	1.32
Weighted Avg Shares Out	4.01M	4.01M	4.01M	4.01M	4.01M	4.01M	4.01M	4.01M	4.01M	4.04M	4.06M	4.05M	4.03M	3.95M	3.94M	3.94M	3.92M	3.91M	3.91M	3.91M	3.90M	3.90M	3.89M	3.90M	3.90M	3.90M	3.60M	3.03M	2.79M	3.56M	3.59M	3.26M
Weighted Avg Shares Out (Dil)	4.01M	4.03M	4.01M	4.01M	4.01M	4.01M	4.01M	4.01M	4.01M	4.04M	4.06M	4.06M	4.03M	3.95M	4.06M	4.04M	4.03M	4.04M	3.99M	3.91M	3.90M	4.06M	3.90M	3.90M	3.90M	3.90M	3.64M	3.03M	2.79M	3.56M	3.59M	3.26M

Is Inovio Pharmaceuticals a Good Buy on Coronavirus Potential?

April 7, 2020investorplace.com

Inovio stock is up on hopes of solving the coronavirus puzzle. But INO stock has plenty of competition in that regard.

Franklin Resources Inc. Buys 196,621 Shares of Steris PLC (NYSE:STE)

April 6, 2020thelincolnianonline.com

Franklin Resources Inc. boosted its stake in Steris PLC (NYSE:STE) by 316.4% in the fourth quarter, HoldingsChannel reports. The firm owned 258,759 shares of the medical equipment provider’s stock after acquiring an additional 196,621 shares during the period. Franklin Resources...

Fulton Bank N.A. Has $225,000 Holdings in Steris PLC (NYSE:STE)

April 5, 2020thelincolnianonline.com

Fulton Bank N.A. reduced its stake in shares of Steris PLC (NYSE:STE) by 33.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,610 shares...

Steris PLC (NYSE:STE) Expected to Post Earnings of $1.63 Per Share

April 4, 2020thelincolnianonline.com

Brokerages expect that Steris PLC (NYSE:STE) will announce earnings of $1.63 per share for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Steris’ earnings. Steris reported earnings per share of $1.53 in the same quarter...

Baird Financial Group Inc. Grows Position in Steris PLC (NYSE:STE)

April 3, 2020thelincolnianonline.com

Baird Financial Group Inc. boosted its position in Steris PLC (NYSE:STE) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,781 shares of the medical equipment provider’s stock after...

Alliancebernstein L.P. Sells 20,345 Shares of Steris PLC (NYSE:STE)

April 3, 2020thelincolnianonline.com

Alliancebernstein L.P. decreased its position in shares of Steris PLC (NYSE:STE) by 12.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 139,442 shares of...

Steris PLC (NYSE:STE) Given Consensus Recommendation of "Buy" by Brokerages

April 3, 2020thelincolnianonline.com

Shares of Steris PLC (NYSE:STE) have been given a consensus rating of “Buy” by the six analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and five have...

$807.53 Million in Sales Expected for Steris PLC (NYSE:STE) This Quarter

April 3, 2020thelincolnianonline.com

Wall Street analysts predict that Steris PLC (NYSE:STE) will report sales of $807.53 million for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Steris’ earnings. The highest sales estimate is $811.50 million and the lowest...

Steris (NYSE:STE) Trading Up 0.1%

April 2, 2020thelincolnianonline.com

Steris PLC (NYSE:STE)’s stock price was up 0.1% on Tuesday . The company traded as high as $140.40 and last traded at $140.19, approximately 46,068 shares traded hands during trading. A decline of 95% from the average daily volume of...